{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:58:58Z","timestamp":1785769138584,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05743-6","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T01:17:21Z","timestamp":1785719841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Apoptosis-inducing potential of tilorone dihydrochloride in triple-negative breast cancer: in silico and in vitro evidences"],"prefix":"10.1007","author":[{"given":"Abu Sufiyan","family":"Chhipa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Boscaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Gallicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejas M.","family":"Dhameliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"5743_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4103\/jcrt.JCRT_41_17","volume":"15","author":"M Alem","year":"2019","unstructured":"Alem M, Shahbazfar AA, Zare P, Tayefi-Nasrabadi H (2019) The effects of coadministration of tilorone dihydrochloride and culture supernatants from Lactobacillus reuteri on the mouse hepatoma cell line. J Cancer Res Ther 15:176\u2013184","journal-title":"J Cancer Res Ther"},{"key":"5743_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.836417","volume":"9","author":"NM Almansour","year":"2022","unstructured":"Almansour NM (2022) Triple-negative breast cancer: a brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence. Front Mol Biosci 9:836417","journal-title":"Front Mol Biosci"},{"key":"5743_CR3","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fphar.2017.00930","volume":"8","author":"AK Bakrania","year":"2017","unstructured":"Bakrania AK, Variya BC, Patel SS (2017) Role of \u03b2-interferon inducer (DEAE-dextran) in tumorigenesis by VEGF and NOTCH1 inhibition along with apoptosis induction. Front Pharmacol 8:930","journal-title":"Front Pharmacol"},{"key":"5743_CR4","doi-asserted-by":"publisher","unstructured":"Bhandari et al (2022) Non-uniformity in in vitro drug-induced cytotoxicity as evidenced by IC50 values. J Pharmacol Toxicol Methods. https:\/\/doi.org\/10.1016\/j.vascn.2022.106085","DOI":"10.1016\/j.vascn.2022.106085"},{"key":"5743_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26185534","volume":"26","author":"V Boscaro","year":"2021","unstructured":"Boscaro V, Barge A, Deagostino A, Ghibaudi E, Laurenti E, Marabello D, Diana E, Gallicchio M (2021) Effects of vanadyl complexes with acetylacetonate derivatives on non-tumor and tumor cell lines. Molecules 26:5534","journal-title":"Molecules"},{"key":"5743_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41698-019-0093-2","volume":"3","author":"NK Brockwell","year":"2019","unstructured":"Brockwell NK, Rautela J, Owen KL, Gearing LJ, Deb S, Harvey K, Spurling A, Zanker D, Chan C-L, Cumming HE, Deng N, Zakhour JM, Duivenvoorden HM, Robinson T, Harris M, White M, Fox J, Ooi C, Kumar B, Thomson J, Potasz N, Swarbrick A, Hertzog PJ, Molloy TJ, Toole SO, Ganju V, Parker BS (2019) Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC. NPJ Precis Oncol 3:21\u201321","journal-title":"NPJ Precis Oncol"},{"key":"5743_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-020-00169-0","volume":"7","author":"AS Chhipa","year":"2021","unstructured":"Chhipa AS, Baksi R, Nivsarkar M (2021) Anticancer studies on methanolic extract of aerial parts of Uraria picta (Jacq.) DC. Future J Pharm Sci 7:16","journal-title":"Future J Pharm Sci"},{"key":"5743_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189204","volume":"1879","author":"AS Chhipa","year":"2024","unstructured":"Chhipa AS, Boscaro V, Gallicchio M, Patel S (2024a) The curious case of type I interferon signaling in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1879:189204","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"5743_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22246","volume":"85","author":"AS Chhipa","year":"2024","unstructured":"Chhipa AS, Sharma A, Verma S, Patel SS (2024b) Therapeutic effects of tilorone on mammary carcinogenesis through downregulation of pro-inflammatory cytokines and oxidative stress. Drug Dev Res 85:e22246","journal-title":"Drug Dev Res"},{"key":"5743_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.178249","volume":"1008","author":"AS Chhipa","year":"2025","unstructured":"Chhipa AS, Gallicchio M, Boscaro V, Patel S (2025) Synergistic anticancer effects of doxorubicin in combination with tilorone in breast cancer. Eur J Pharmacol 1008:178249","journal-title":"Eur J Pharmacol"},{"key":"5743_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202302471","volume":"9","author":"TM Dhameliya","year":"2024","unstructured":"Dhameliya TM, Vekariya DD, Vaddoriya VN, Trivedi YM, Patel KR, Dholakia SP (2024) Recent advancements and developments of molecular dynamics simulations in the discovery of anti-protozoal agents. ChemistrySelect 9:e202302471","journal-title":"ChemistrySelect"},{"key":"5743_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/iub.1379","volume":"67","author":"SS Dhumale","year":"2015","unstructured":"Dhumale SS, Waghela BN, Pathak C (2015) Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells. IUBMB Life 67:361\u2013373","journal-title":"IUBMB Life"},{"key":"5743_CR13","doi-asserted-by":"publisher","first-page":"13792","DOI":"10.1073\/pnas.1713728114","volume":"114","author":"MR Doherty","year":"2017","unstructured":"Doherty MR, Cheon H, Junk DJ, Vinayak S, Varadan V, Telli ML, Ford JM, Stark GR, Jackson MW (2017) Interferon-beta represses cancer stem cell properties in triple-negative breast cancer. Proc National Acad Sci 114:13792\u201313797","journal-title":"Proc National Acad Sci"},{"key":"5743_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13058-019-1136-x","volume":"21","author":"MR Doherty","year":"2019","unstructured":"Doherty MR, Parvani JG, Tamagno I, Junk DJ, Bryson BL, Cheon HJ, Stark GR, Jackson MW (2019) The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer. Breast Cancer Res 21:54","journal-title":"Breast Cancer Res"},{"issue":"3","key":"5743_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2022.8362","volume":"48","author":"N Dwivedi","year":"2022","unstructured":"Dwivedi N, Gangadharan C, Pillai V, Kuriakose MA, Suresh A, Das M (2022) Establishment and characterization of novel autologous pair cell lines from two Indian non-habitual tongue carcinoma patients. Oncol Rep 48(3):1\u201312","journal-title":"Oncol Rep"},{"issue":"2","key":"5743_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.01711-17","volume":"62","author":"S Ekins","year":"2018","unstructured":"Ekins S, Lingerfelt MA, Comer JE, Freiberg AN, Mirsalis JC, O\u2019Loughlin K, Harutyunyan A, McFarlane C, Green CE, Madrid PB (2018) Efficacy of tilorone dihydrochloride against Ebola virus infection. Antimicrob Agents Chemother 62(2):10\u20131128","journal-title":"Antimicrob Agents Chemother"},{"key":"5743_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11095-020-02799-8","volume":"37","author":"S Ekins","year":"2020","unstructured":"Ekins S, Lane TR, Madrid PB (2020) Tilorone: a broad-spectrum antiviral invented in the USA and commercialized in Russia and beyond. Pharm Res 37:71","journal-title":"Pharm Res"},{"key":"5743_CR18","first-page":"52","volume":"4","author":"FI Ershov","year":"1999","unstructured":"Ershov FI, Tazulakhova EB (1999) Interferon inducers: new generation of immunomodulators. Vestnik Ross Akad Med Nauk 4:52\u201356","journal-title":"Vestnik Ross Akad Med Nauk"},{"key":"5743_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13287-018-0987-x","volume":"9","author":"W Gao","year":"2018","unstructured":"Gao W, Wu D, Wang Y, Wang Z, Zou C, Dai Y, Ng C-F, Teoh JY-C, Chan FL (2018) Development of a novel and economical agar-based non-adherent three-dimensional culture method for enrichment of cancer stem-like cells. Stem Cell Res Ther 9:243","journal-title":"Stem Cell Res Ther"},{"key":"5743_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/microorganisms10010092","volume":"10","author":"KN Johnson","year":"2022","unstructured":"Johnson KN, Kalveram B, Smith JK, Zhang L, Juelich T, Atkins C, Ikegami T, Freiberg AN (2022) Tilorone-dihydrochloride protects against rift valley fever virus infection and disease in the mouse model. Microorganisms 10:92","journal-title":"Microorganisms"},{"key":"5743_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1089\/107999004323034105","volume":"24","author":"S-H Juang","year":"2004","unstructured":"Juang S-H, Wei S-J, Hung Y-M, Hsu C-Y, Yang D-M, Liu K-J, Chen W-S, Yang WK (2004) IFN-\u03b2 induces caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell lines. J Interferon Cytokine Res 24:231\u2013243","journal-title":"J Interferon Cytokine Res"},{"key":"5743_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3181\/00379727-137-35576","volume":"137","author":"HE Kaufman","year":"1971","unstructured":"Kaufman HE, Centifanto YM, Ellison ED, Brown DC (1971) Tilorone hydrochloride: human toxicity and interferon stimulation. Proc Soc Exp Biol Med 137:357\u2013360","journal-title":"Proc Soc Exp Biol Med"},{"key":"5743_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81701-x","volume":"11","author":"M Kumari","year":"2021","unstructured":"Kumari M, Sharma N, Manchanda R, Gupta N, Syed A, Bahkali AH, Nimesh S (2021) PGMD\/curcumin nanoparticles for the treatment of breast cancer. Sci Rep 11:3824","journal-title":"Sci Rep"},{"key":"5743_CR24","doi-asserted-by":"crossref","unstructured":"Kung C-P, Cottrell KA, Ryu S, Bramel ER, Kladney RD, Bao EA, Freeman EC, Sabloak T, Maggi L Jr, Weber JD (2021) Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer. Oncogene 40:189\u2013202","DOI":"10.1038\/s41388-020-01515-5"},{"key":"5743_CR25","doi-asserted-by":"publisher","unstructured":"Larsson Engqvist et al. (Theile D et al.) (2020) Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens. Sci Rep. 10(1):5798. https:\/\/doi.org\/10.1038\/s41598-020-62848-5","DOI":"10.1038\/s41598-020-62848-5"},{"key":"5743_CR26","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 121:2750\u20132767","journal-title":"J Clin Invest"},{"key":"5743_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14364-2","volume":"7","author":"W Li","year":"2017","unstructured":"Li W, Ma H, Zhang J, Zhu L, Wang C, Yang Y (2017) Unraveling the roles of CD44\/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis. Sci Rep 7:13856","journal-title":"Sci Rep"},{"key":"5743_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114689","volume":"283","author":"M Li","year":"2022","unstructured":"Li M, Guo T, Lin J, Huang X, Ke Q, Wu Y, Fang C, Hu C (2022) Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog\/Gli1 signaling pathway. J Ethnopharmacol 283:114689","journal-title":"J Ethnopharmacol"},{"key":"5743_CR29","doi-asserted-by":"publisher","DOI":"10.3791\/52671","author":"Y Lombardo","year":"2015","unstructured":"Lombardo Y, de Giorgio A, Coombes CR, Stebbing J, Castellano L (2015) Mammosphere formation assay from human breast cancer tissues and cell lines. J Visualized Exp Jove. https:\/\/doi.org\/10.3791\/52671","journal-title":"J Visualized Exp Jove"},{"key":"5743_CR30","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/bjc.2015.85","volume":"112","author":"J Lopez","year":"2015","unstructured":"Lopez J, Tait SWG (2015) Mitochondrial apoptosis: killing cancer using the enemy within. Br J Cancer 112:957\u2013962","journal-title":"Br J Cancer"},{"key":"5743_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113527","volume":"425","author":"L Mahmoud","year":"2023","unstructured":"Mahmoud L, Cougnoux A, Bekiari C, Araceli Ruiz de Castroviejo Teba P, El Marrahi A, Panneau G, Gsell L, Hausser J (2023) Microscopy-based phenotypic monitoring of MDA-MB-231 spheroids allows the evaluation of phenotype-directed therapy. Exp Cell Res 425:113527","journal-title":"Exp Cell Res"},{"key":"5743_CR32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"XY Meng","year":"2011","unstructured":"Meng XY, Zhang HX, Mezei M, Cui M (2011) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug des 7:146\u2013157","journal-title":"Curr Comput Aided Drug des"},{"key":"5743_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1615\/CritRevEukaryotGeneExpr.2013006875","volume":"24","author":"J Morales","year":"2014","unstructured":"Morales J, Li L, Fattah FJ, Dong Y, Bey EA, Patel M, Gao J, Boothman DA (2014) Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases. Crit Rev Eukaryot Gene Expr 24:15\u201328","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"5743_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/scrt506","volume":"5","author":"S Mukherjee","year":"2014","unstructured":"Mukherjee S, Mazumdar M, Chakraborty S, Manna A, Saha S, Khan P, Bhattacharjee P, Guha D, Adhikary A, Mukhjerjee S, Das T (2014) Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin\/\u03b2-catenin negative feedback loop. Stem Cell Res Ther 5:116","journal-title":"Stem Cell Res Ther"},{"key":"5743_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41420-019-0142-1","volume":"5","author":"KG Ponder","year":"2019","unstructured":"Ponder KG, Boise LH (2019) The prodomain of caspase-3 regulates its own removal and caspase activation. Cell Death Discov 5:56","journal-title":"Cell Death Discov"},{"key":"5743_CR36","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1111\/jcmm.14090","volume":"23","author":"M Rahimi","year":"2019","unstructured":"Rahimi M, Sharifi-Zarchi A, Firouzi J, Azimi M, Zarghami N, Alizadeh E, Ebrahimi M (2019) An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in breast cancer stem cells. J Cell Mol Med 23:2442\u20132456","journal-title":"J Cell Mol Med"},{"key":"5743_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/pr9010071","volume":"9","author":"OMH Salo-Ahen","year":"2021","unstructured":"Salo-Ahen OMH, Alanko I, Bhadane R, Bonvin AMJJ, Honorato RV, Hossain S, Juffer AH, Kabedev A, Lahtela-Kakkonen M, Larsen AS, Lescrinier E, Marimuthu P, Mirza MU, Mustafa G, Nunes-Alves A, Pantsar T, Saadabadi A, Singaravelu K, Vanmeert M (2021) Molecular dynamics simulations in drug discovery and pharmaceutical development. Processes 9:71","journal-title":"Processes"},{"key":"5743_CR38","doi-asserted-by":"crossref","unstructured":"Saunders AAE, Mouchemore KA, Vojtech L, James LS, Chadwick TB, Chi LH, Karagiannis C, Bell C, Thomson RE, Parker BS, Anderson RL, Gregorevic P (2026) Reduction of primary tumor growth and metastasis in models of triple-negative breast cancer following tilorone administration via type I interferon signaling. Breast Cancer Res","DOI":"10.1186\/s13058-026-02296-7"},{"key":"5743_CR39","doi-asserted-by":"publisher","first-page":"e202405449","DOI":"10.1002\/slct.202405449","volume":"10","author":"VN Savaliya","year":"2025","unstructured":"Savaliya VN, Rastogi P, Savaliya PD, Salaria P, Reddy MA, Vyas VK, Natesan G, Dhameliya TM (2025) Investigations through in silico molecular modelling against falcipain-2 in search of potent anti-malarial agents. ChemistrySelect 10:e202405449","journal-title":"ChemistrySelect"},{"key":"5743_CR40","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1158\/2159-8290.CD-18-1454","volume":"9","author":"J Sceneay","year":"2019","unstructured":"Sceneay J, Goreczny GJ, Wilson K, Morrow S, DeCristo MJ, Ubellacker JM, Qin Y, Laszewski T, Stover DG, Barrera V, Hutchinson JN, Freedman RA, Mittendorf EA, McAllister SS (2019) Interferon signaling is diminished with age and is associated with immune checkpoint blockade efficacy in triple-negative breast cancer. Cancer Discov 9:1208\u20131227","journal-title":"Cancer Discov"},{"key":"5743_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-018-0850-9","volume":"17","author":"Y Shi","year":"2018","unstructured":"Shi Y, Jin J, Ji W, Guan X (2018) Therapeutic landscape in mutational triple negative breast cancer. Mol Cancer 17:99","journal-title":"Mol Cancer"},{"key":"5743_CR42","first-page":"3528","volume":"52","author":"YA Sidky","year":"1992","unstructured":"Sidky YA, Borden EC, Weeks CE, Reiter MJ, Hatcher JF, Bryan GT (1992) Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine. Cancer Res 52:3528\u20133533","journal-title":"Cancer Res"},{"key":"5743_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.abb.2018.02.011","volume":"643","author":"J Suh","year":"2018","unstructured":"Suh J, Kim DH, Surh YJ (2018) Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk. Arch Biochem Biophys 643:62\u201371","journal-title":"Arch Biochem Biophys"},{"key":"5743_CR44","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41418-025-01457-z","volume":"32","author":"Y Sun","year":"2025","unstructured":"Sun Y, Aliyari SR, Parvatiyar K, Wang L, Zhen A, Sun W, Han X, Zhang A, Kato E, Shi H, De Schutter E, McBride WH, French SW, Cheng G (2025) STING directly interacts with PAR to promote apoptosis upon acute ionizing radiation-mediated DNA damage. Cell Death Differ 32:1167\u20131179","journal-title":"Cell Death Differ"},{"key":"5743_CR45","doi-asserted-by":"crossref","unstructured":"Waghela BN, Sharma A, Dhumale S, Pandey SM, Pathak C (2015) Curcumin conjugated with PLGA potentiates sustainability, anti-proliferative activity and apoptosis in human colon carcinoma cells. PLoS One 10:e0117526","DOI":"10.1371\/journal.pone.0117526"},{"key":"5743_CR46","first-page":"829","volume":"6","author":"R Wang","year":"2014","unstructured":"Wang R, Lv Q, Meng W, Tan Q, Zhang S, Mo X, Yang X (2014) Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors. J Thorac Dis 6:829\u2013837","journal-title":"J Thorac Dis"},{"key":"5743_CR47","doi-asserted-by":"publisher","unstructured":"Wang et al (2026) Benchmarking deep learning models for predicting anticancer drug sensitivity. Commun Chem. https:\/\/doi.org\/10.1038\/s42004-026-01916-9","DOI":"10.1038\/s42004-026-01916-9"},{"key":"5743_CR48","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1158\/1538-7445.AM2011-2976","volume":"71","author":"MD Wissing","year":"2011","unstructured":"Wissing MD, Kim E, Dadon T, Shim JS, Mendonca J, Piontek K, Liu JO, Carducci MA, Kachhap SK, Nelkin BD (2011) Abstract 2976: Small molecule screening of prostate and pancreatic cancer cell lines identifies tilorone dihydrochloride as a compound that selectively inhibits growth in cells with inhibited cyclin-dependent kinase 5. Can Res 71:2976\u20132976","journal-title":"Can Res"},{"key":"5743_CR49","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3892\/or.2014.3174","volume":"32","author":"MD Wissing","year":"2014","unstructured":"Wissing MD, Dadon T, Kim E, Piontek KB, Shim JS, Kaelber NS, Liu JO, Kachhap SK, Nelkin BD (2014) Small-molecule screening of PC3 prostate cancer cells identifies tilorone dihydrochloride to selectively inhibit cell growth based on cyclin-dependent kinase 5 expression. Oncol Rep 32:419\u2013424","journal-title":"Oncol Rep"},{"key":"5743_CR50","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/cbdd.13860","volume":"98","author":"P Yadav","year":"2021","unstructured":"Yadav P, Yadav R, Jain S, Vaidya A (2021) Caspase-3: a primary target for natural and synthetic compounds for cancer therapy. Chem Biol Drug des 98:144\u2013165","journal-title":"Chem Biol Drug des"},{"key":"5743_CR51","doi-asserted-by":"publisher","first-page":"807","DOI":"10.4149\/neo_2022_211012N1441","volume":"69","author":"M Yuan","year":"2022","unstructured":"Yuan M, Guo XL, Chen JH, He Y, Liu ZQ, Zhang HP, Ren J, Xu Q (2022) Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING\/IFN-\u03b2 pathway. Neoplasma 69:807\u2013819","journal-title":"Neoplasma"},{"key":"5743_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00468-0","volume":"8","author":"P Zagami","year":"2022","unstructured":"Zagami P, Carey LA (2022) Triple negative breast cancer: pitfalls and progress. Npj Breast Cancer 8:95","journal-title":"Npj Breast Cancer"},{"key":"5743_CR53","doi-asserted-by":"publisher","first-page":"e1177","DOI":"10.1002\/cti2.1177","volume":"9","author":"DJ Zanker","year":"2020","unstructured":"Zanker DJ, Spurling AJ, Brockwell NK, Owen KL, Zakhour JM, Robinson T, Duivenvoorden HM, Hertzog PJ, Mullins SR, Wilkinson RW, Parker BS (2020) Intratumoral administration of the Toll-like receptor 7\/8 agonist 3M\u2013052 enhances interferon-driven tumor immunogenicity and suppresses metastatic spread in preclinical triple-negative breast cancer. Clin Transl Immunol 9:e1177","journal-title":"Clin Transl Immunol"},{"key":"5743_CR54","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.molcel.2013.05.022","volume":"51","author":"X Zhang","year":"2013","unstructured":"Zhang X, Shi H, Wu J, Zhang X, Sun L, Chen C, Chen ZJ (2013) Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell 51:226\u2013235","journal-title":"Mol Cell"},{"key":"5743_CR55","doi-asserted-by":"publisher","first-page":"21458","DOI":"10.3390\/molecules201219781","volume":"20","author":"J Zhang","year":"2015","unstructured":"Zhang J, Yao Q, Liu Z (2015) An effective synthesis method for tilorone dihydrochloride with obvious IFN-\u03b1 inducing activity. Mol (Basel, Switzerland) 20:21458\u201321463","journal-title":"Mol (Basel, Switzerland)"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05743-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05743-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05743-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:03:45Z","timestamp":1785765825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05743-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":55,"alternative-id":["5743"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05743-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}